Why Women V Cancer?
Created in 2010, Women V Cancer had two aims:
- To help put an end to women’s cancers and
- To get more women on their bikes
Since then, over twenty thousand amazing women have taken part in one or several of the Women V Cancer challenges and together the partnership has raised over £22 million in 14 years for women impacted by cancer.
Cycling Against Cancer Together
The Women V Cancer partnership brings together the cancer charities Breast Cancer Now and Ovarian Cancer Action who provide crucial life-saving support to countless people facing cancer. They educate thousands of people about the signs and symptoms of breast and ovarian cancers and carry-out cutting-edge research into treatments and cures.
Through the Women V Cancer challenges, these charities bring thousands of women together every year raising vital funds to support women impacted by cancer.
Breast Cancer Now
We’re Breast Cancer Now. We’re here to change the lives of people affected by breast cancer. How? By combining the power of research and support.
Our world-class researchers are working in labs across the UK and Ireland to create a world where the words “breast cancer” aren’t met with fear. We’re building a brighter future for everyone affected by breast cancer.
And because over 600,000 people are living with or beyond the disease, we’re here with support for today, too. Every step of the way.
By taking on a Women v Cancer challenge, you are making a difference for everyone affected by breast cancer.
Ovarian Cancer Action
We are the UK’s ovarian cancer research charity. We lead lifesaving research breakthroughs for every woman.
We back researchers’ cutting-edge discoveries. We team up with clinicians trialling new treatments. And, with our inspiring community, we campaign for equal access to treatment for women of every age, race and postcode.
In the UK just 1 in 3 women live more than five years after diagnosis. Ovarian Cancer Action want to change this.
The money raised through Women V Cancer helps our work to better prevent, treat and spot ovarian cancer, so that by 2032 at least half of women with ovarian cancer live for 10 years.